Lopinavir/ritonavir Accord 200 mg/50 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lopinavir/ritonavir accord 200 mg/50 mg filmom obložene tablete

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - lopinavir ritonavir - filmom obložena tableta - 200 mg + 50 mg - urbroj: svaka filmom obložena tableta sadrži 200 mg lopinavira u kombinaciji s 50 mg ritonavira, kao farmakokinetičkog pojačivača

Darunavir Accord 800 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

darunavir accord 800 mg filmom obložene tablete

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - darunavirpropilenglikolat - filmom obložena tableta - 800 mg - urbroj: jedna filmom obložena tableta sadrži 800 mg darunavira (u obliku darunavirpropilenglikolata)

INTEGRIRANI SUSTAVI ZA KLINIČKU KEMIJU Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

integrirani sustavi za kliniČku kemiju

medi- lab d.o.o., zagreb - in vitro dijagnostika, analizatori za određivanje biokemijskih parametara

Xeljanz Europska Unija - hrvatski - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - Тофацитиниб - artritis, reumatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 i 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Genvoya Europska Unija - hrvatski - EMA (European Medicines Agency)

genvoya

gilead sciences ireland uc - элвитегравир, кобицистат, эмтрицитабин, Тенофовир alafenamide - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - genvoya je indiciran za liječenje odraslih i adolescenata (u dobi od 12 godina i stariji sa tjelesne težine najmanje 35 kg) zaraženih virusom humane imunodeficijencije (hiv-a 1) 1 bez bilo koje poznate mutacija povezanih s rezistencijom na inhibitora integraze, emtricitabin ili tenofovir.

Biktarvy Europska Unija - hrvatski - EMA (European Medicines Agency)

biktarvy

gilead sciences ireland uc - bictegravir, эмтрицитабин, Тенофовир alafenamide, фумарат - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (vidi odjeljak 5.

Lenalidomid Labormed 10 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 10 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 10 mg - urbroj: jedna kapsula sadrži 10 mg lenalidomida

Lenalidomid Labormed 15 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 15 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 15 mg - urbroj: jedna kapsula sadrži 15 mg lenalidomida